Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients

SIMPLE SUMMARY: Vaccination is the primary public health strategy to cope with the COVID-19 pandemic. Although solid tumor and hematologic patients are at higher risk of serious COVID-19-related complications and mortality, data on immune responses to COVID-19 vaccines in this patient cohort are par...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Josef, Le, Nguyen-Son, Mattes, Daniel, Klamminger, Valerie, Hackner, Klaus, Kolinsky, Nicole, Scherb, Michaela, Errhalt, Peter, Kreye, Gudrun, Pecherstorfer, Martin, Vallet, Sonia, Podar, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430869/
https://www.ncbi.nlm.nih.gov/pubmed/34503127
http://dx.doi.org/10.3390/cancers13174312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430869/
https://www.ncbi.nlm.nih.gov/pubmed/34503127
http://dx.doi.org/10.3390/cancers13174312

Ejemplares similares